Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1997 Aug 4;186(3):439-48.
doi: 10.1084/jem.186.3.439.

Disruption of the Bcl6 gene results in an impaired germinal center formation

Affiliations

Disruption of the Bcl6 gene results in an impaired germinal center formation

T Fukuda et al. J Exp Med. .

Abstract

The Bcl6 gene has been identified from the chromosomal translocation breakpoint in B cell lymphomas, and its products are expressed highly in germinal center (GC) B cells. To investigate the function of Bcl6 in lymphocytes, we have generated RAG1-deficient mice reconstituted with bone marrow cells from Bcl6-deficient mice (Bcl6(-/-)RM). Lymphogenesis in primary lymphoid tissues of Bcl6(-/-)RM is normal, and Bcl6(-/-)RM produced control levels of primary IgG1 antibodies specific to T cell-dependent antigens. However, GCs were not found in these mice. This defect was mainly due to the abnormalities of B cells. Therefore, Bcl6 is essential for the differentiation of GC B cells.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Bcl6 expression in spleen from immunized C57BL/6. Spleen sections from C57BL/6 mice on day 14 (A and B) or day 7 (C and D) after immunization were stained with anti-Bcl6 Ab (A and B) or anti-Bcl6 and anti-λ light chain Abs (C and D). Brown signals in nuclei and membranous blue signals indicate Bcl6 protein and λ light chain, respectively. Sections were counterstained with hematoxylin (A and B). Arrows and arrowheads indicate centroblasts and centrocytes respectively.
Figure 2
Figure 2
Normal development of B and T cells in Bcl6−/−RM. Representative flow cytometric analysis of BM cells (A), thymocytes (B), and splenocytes (C and D) from Bcl6+/+RM (left column) and Bcl6−/−RM (right column). Numbers indicate relative percentages of positive cells within a quadrant.
Figure 3
Figure 3
Control levels of primary Abs in sera from immunized Bcl6−/−RM. Bcl6−/−RM (closed circles) and Bcl6+/+RM (open circles) were immunized with DNP–OVA. IgM and IgG1 anti-DNP titers in the sera were measured by ELISA.
Figure 4
Figure 4
GC formation is impaired in spleen from Bcl6−/−RM. Splenocytes from Bcl6+/+RM (A) and Bcl6−/−RM (B) immunized with DNP–OVA on day 14 after immunization were stained with PNA and anti-B220 Ab. The numbers in the figures indicate percentages of PNAhigh B220+ cells relative to total B220+ cells. Splenic sections from the immunized Bcl6+/+RM (C and E) and Bcl6−/−RM (D and F) were stained with PNA (C and D) or anti-B220 Ab (E and F) (brown). Hematoxylin counterstain. G, germinal center; T, T cell–rich PALS; M, marginal zone; F, primary follicle.
Figure 4
Figure 4
GC formation is impaired in spleen from Bcl6−/−RM. Splenocytes from Bcl6+/+RM (A) and Bcl6−/−RM (B) immunized with DNP–OVA on day 14 after immunization were stained with PNA and anti-B220 Ab. The numbers in the figures indicate percentages of PNAhigh B220+ cells relative to total B220+ cells. Splenic sections from the immunized Bcl6+/+RM (C and E) and Bcl6−/−RM (D and F) were stained with PNA (C and D) or anti-B220 Ab (E and F) (brown). Hematoxylin counterstain. G, germinal center; T, T cell–rich PALS; M, marginal zone; F, primary follicle.
Figure 5
Figure 5
PALS-associated focus formation is not impaired in spleen from Bcl6−/−RM. Splenic sections from Bcl6+/+RM (A) and Bcl6−/−RM (B) immunized with NP–CG on day 7 after immunization were stained with anti-λ light chain Abs (blue) and PNA (brown).
Figure 6
Figure 6
B cells are responsible for the defect of GC formation in Bcl6−/− RM. Spleen sections from the DNP–OVA immunized RAG1−/− reconstituted with B cells from Bcl6+/+ RM and T cells from Bcl6−/− RM (A), or with B cells from Bcl6−/−RM and T cells from Bcl6+/+RM (B) were stained with PNA (brown). Hematoxylin counterstain.
Figure 7
Figure 7
Nascent GC is absent in spleen from Bcl6−/−RM. Spleen sections from Bcl6+/+RM (A) and Bcl6−/−RM (B) on day 3 after immunization were stained with anti-BrdU Ab and PNA. Strong blue signals in the nuclei and membranous weak blue signals indicate BrdU uptake and cell surface Igs, respectively. Brown signals in follicle of Bcl6+/+RM indicate PNA-reactive GC cells.
Figure 8
Figure 8
Proliferation capacity of splenic B cells from Bcl6−/−RM. Proliferative responses of splenic B cells from Bcl6+/+RM (shaded bars) and Bcl6−/−RM (closed bars) to indicated stimuli. Results represent means and variations (SD) from triplicate cultures. The data presented are representative of three independent experiments.

Similar articles

Cited by

References

    1. Kerchaert JP, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nature Genet. 1993;5:66–70. - PubMed
    1. Ye BH, Lista F, Lo DM, Coco, Knoeles R, Offit K, Chaganti R SK, Dalla-Favera R. Alterations of a zinc finger–encoding gene, BCL-6, in diffuse large-cell lymphoma. Science (Wash DC) 1993;262:747–750. - PubMed
    1. Miki T, Kawamata N, Hirosawa S, Aoki N. Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Krüppel-like zinc-finger protein. Blood. 1994;83:26–32. - PubMed
    1. Bastard C, Deweindt C, Kerchaert JP, Leormand B, Rossi A, Pezzela F, Fruchart C, Duval C, Monconduit M, Tilly H. LAZ3rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome. Blood. 1994;83:2423–2427. - PubMed
    1. Lo Coco, F., B.H. Ye, F. Lista., P. Corradini, K. Offit, R. Knoeles, R.S.K. Chaganti, and R. Dalla-Favera. Rearrangements of the BCL6gene in diffuse large cell non-Hodgkin's lymphoma. Blood. 1994;83:1757–1759. - PubMed

Publication types

MeSH terms